Browsing Tag
Napazimone
1 post
Pharming Group tightens 2026 revenue guidance to $380m–$390m after strong third-quarter sales
Pharming Group Q3 revenue rises 21% to $117.6 million as Joenja sales jump 58%. Explore revised guidance, expenses and investor outlook.